剔毒护肝方对门脉高压性胃病患者血清胃泌素和胰高糖素的影响

探讨剔毒护肝方对门脉高压性胃病(PHG)患者血清胃泌素和胰高糖素的影响。方法:用剔毒护肝方治疗肝硬化失代偿期合并门脉高压性胃病患者46例,与辅酶Q_(10)治疗的38例作对照,疗程3个月,采用放免法测定治疗前后两组患者的血清胃泌素和胰高糖素的水平。结果:经剔毒护肝方治疗后,血清胃泌素由治疗前的78.64±19.31Pg/ml下降到治疗后的51.36±21.35pg/ml,胰高糖素由66.54±27.61Pg/ml上升到84.64±23.61pg/ml,与对照组比较,具有显著差异。结论:剔毒护肝方具有调节PHG患者血清胃泌素和胰高糖素水平的作用。